PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
MATW vs. IOVA
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between MATW and IOVA is 0.16, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

MATW vs. IOVA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Matthews International Corporation (MATW) and Iovance Biotherapeutics, Inc. (IOVA). The values are adjusted to include any dividend payments, if applicable.

-100.00%-80.00%-60.00%-40.00%-20.00%0.00%20.00%JulyAugustSeptemberOctoberNovemberDecember
1.57%
-93.29%
MATW
IOVA

Key characteristics

Sharpe Ratio

MATW:

-0.54

IOVA:

0.03

Sortino Ratio

MATW:

-0.62

IOVA:

0.78

Omega Ratio

MATW:

0.93

IOVA:

1.09

Calmar Ratio

MATW:

-0.34

IOVA:

0.03

Martin Ratio

MATW:

-0.77

IOVA:

0.07

Ulcer Index

MATW:

29.36%

IOVA:

38.72%

Daily Std Dev

MATW:

42.41%

IOVA:

88.51%

Max Drawdown

MATW:

-75.27%

IOVA:

-99.37%

Current Drawdown

MATW:

-56.66%

IOVA:

-95.36%

Fundamentals

Market Cap

MATW:

$904.30M

IOVA:

$2.39B

EPS

MATW:

-$1.93

IOVA:

-$1.48

PEG Ratio

MATW:

1.92

IOVA:

0.00

Total Revenue (TTM)

MATW:

$1.48B

IOVA:

$90.86M

Gross Profit (TTM)

MATW:

$205.12M

IOVA:

-$12.33M

EBITDA (TTM)

MATW:

$81.86M

IOVA:

-$396.36M

Returns By Period

In the year-to-date period, MATW achieves a -22.27% return, which is significantly lower than IOVA's -9.23% return. Over the past 10 years, MATW has underperformed IOVA with an annualized return of -3.44%, while IOVA has yielded a comparatively higher -0.81% annualized return.


MATW

YTD

-22.27%

1M

15.32%

6M

12.18%

1Y

-24.36%

5Y*

-3.25%

10Y*

-3.44%

IOVA

YTD

-9.23%

1M

-9.34%

6M

-7.87%

1Y

-6.46%

5Y*

-24.19%

10Y*

-0.81%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

MATW vs. IOVA - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Matthews International Corporation (MATW) and Iovance Biotherapeutics, Inc. (IOVA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for MATW, currently valued at -0.54, compared to the broader market-4.00-2.000.002.00-0.540.03
The chart of Sortino ratio for MATW, currently valued at -0.62, compared to the broader market-4.00-2.000.002.004.00-0.620.78
The chart of Omega ratio for MATW, currently valued at 0.93, compared to the broader market0.501.001.502.000.931.09
The chart of Calmar ratio for MATW, currently valued at -0.34, compared to the broader market0.002.004.006.00-0.340.03
The chart of Martin ratio for MATW, currently valued at -0.77, compared to the broader market-5.000.005.0010.0015.0020.0025.00-0.770.07
MATW
IOVA

The current MATW Sharpe Ratio is -0.54, which is lower than the IOVA Sharpe Ratio of 0.03. The chart below compares the historical Sharpe Ratios of MATW and IOVA, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.00JulyAugustSeptemberOctoberNovemberDecember
-0.54
0.03
MATW
IOVA

Dividends

MATW vs. IOVA - Dividend Comparison

MATW's dividend yield for the trailing twelve months is around 3.52%, while IOVA has not paid dividends to shareholders.


TTM20232022202120202019201820172016201520142013
MATW
Matthews International Corporation
3.52%2.54%2.92%2.36%2.87%2.12%1.90%1.33%0.81%1.01%0.95%0.96%
IOVA
Iovance Biotherapeutics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

MATW vs. IOVA - Drawdown Comparison

The maximum MATW drawdown since its inception was -75.27%, smaller than the maximum IOVA drawdown of -99.37%. Use the drawdown chart below to compare losses from any high point for MATW and IOVA. For additional features, visit the drawdowns tool.


-100.00%-90.00%-80.00%-70.00%-60.00%-50.00%JulyAugustSeptemberOctoberNovemberDecember
-56.66%
-95.36%
MATW
IOVA

Volatility

MATW vs. IOVA - Volatility Comparison

Matthews International Corporation (MATW) has a higher volatility of 22.93% compared to Iovance Biotherapeutics, Inc. (IOVA) at 17.60%. This indicates that MATW's price experiences larger fluctuations and is considered to be riskier than IOVA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%30.00%JulyAugustSeptemberOctoberNovemberDecember
22.93%
17.60%
MATW
IOVA

Financials

MATW vs. IOVA - Financials Comparison

This section allows you to compare key financial metrics between Matthews International Corporation and Iovance Biotherapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab